Improving HER2 Targeting in NSCLC With Selective TKI
HER2 activation plays a crucial role in promoting tumor proliferation and survival in NSCLC. Driven by oncogenic downstream signaling pathways, HER2 overexpression and gene amplification lead to the formation of heterodimers and activation of key signaling cascades. Additionally, HER2 mutations are
0 views • 36 slides
Detection of Mutations in EGFR in Circulating Lung Cancer Cells: Study on SARMS Assay and CTC-Chip
This study by Shyamala Maherswaran, Ph.D., and team focuses on characterizing mutations in EGFR in circulating tumor cells using SARMS assay and CTC-chip. The research investigates the effectiveness of these non-invasive methods in analyzing tumors and explores the role of the T790M mutation in resp
0 views • 12 slides